HomeMarketsSharesAkebia Ther

Trade Akebia Ther - AKBA CFD

1.4234+2.15%
The chart shows the AKBA stock price data over the last 1 day, with a current price of 1.4234, a high of 1.4366, and a low of 1.3866.
Sell

1.4066

Buy

1.4234

0.0168
Low: 1.3866High: 1.4366
Sellers:
50%
Buyers:
50%
Past performance is not a reliable indicator of future results
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.0168
Long position overnight funding adjustment
Long position overnight funding adjustment
Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021485 %
(-$0.43)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $1,000.00

-0.02149%
Short position overnight funding adjustment
Short position overnight funding adjustment
Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000738 %
(-$0.01)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $1,000.00

-0.00074%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin50.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close1.4166
Open1.4166
1-Year Change-50.23%
Day's Range1.3866 - 1.4366

What is Akebia Ther (AKBA)?

Akebia Therapeutics, Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for patients with kidney disease and related conditions. The company focuses on treatments that address anemia associated with chronic kidney disease and other renal disorders. Akebia Therapeutics invests in research and development to advance its product candidates through clinical trials and regulatory approval processes. Its portfolio includes drugs designed to improve patient outcomes by targeting specific pathways involved in kidney function and disease progression. The company collaborates with healthcare providers and regulatory agencies to support the availability of its therapies. Akebia Therapeutics operates within the pharmaceutical industry, emphasizing innovation in nephrology.

Akebia Ther Stock Price Today: Live Overview

The price today is shaped by live market conditions, as Akebia Ther trades at $1.4234. It has moved within the range of $1.3866 to $1.4466 today, changing by -0.7109%.

FAQ: Akebia Ther (AKBA)

What is the current price of AKBA stock?

The current trading price is $1.4234.

Does AKBA pay dividends?

Akebia Therapeutics does not pay dividends.

Does AKBA have a formal corporate presence or regional headquarters in the UAE?

Akebia Therapeutics has no official presence in the UAE and operates through partners or distributors.

What is AKBA best known for?

The company is most famous for developing treatments for kidney disease.

What assets are typically shown together with AKBA?

Commonly shown alongside AKBA: ACCO Brands Corp, Kyntra Bio Inc, Bio-Techne Corp

Latest shares articles

NVIDIA logo
NVIDIA ignites risk appetite as markets close the week on a stronger footing
NVIDIA's strong results drive sentiment higher as investors had began to doubt the AI narrative.
11:43, 26 February 2026
Tesla stock forecast
Tesla stock forecast: Could Q1 2026 earnings lift targets?
Tesla (TSLA) is a US-listed automotive and clean energy company whose shares trade on the Nasdaq and are closely monitored for earnings performance, delivery data and developments in technology and manufacturing. Explore third-party TSLA price targets and technical analysis.
17:23, 23 February 2026
Siemens Energy stock forecast
Siemens Energy stock forecast: Third-party price targets
Siemens Energy AG is a Germany-based energy technology company listed in Frankfurt, supplying equipment and services across power generation, grids and energy-transition projects. Explore third-party ENR price targets and technical analysis.
15:04, 3 February 2026
BYD Company stock forecast: Third-party price targets
BYD Company stock forecast: Third-party price targets
BYD Company is a Hong Kong–listed automotive manufacturer focused on electric vehicles and plug-in hybrids, with operations covering vehicle production, batteries and related technologies across domestic and overseas markets. Explore third-party 1211 price targets and technical analysis.
14:23, 3 February 2026

Read our reviews to find out more about us

Read the feedback from our clients around the world.
2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews across TradingView, App Store, Google Play and Trustpilot.

4.8
Ratings and Reviews
4.7
Ratings and Reviews
4.7
4.6

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading